TCL Archive Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed December 12, 1975
TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001
TCL Archive NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies. October 31, 2008
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
